Apicomplexan infections in the gut
- PMID: 25201405
- DOI: 10.1111/pim.12115
Apicomplexan infections in the gut
Abstract
Toxoplasma gondii and Cryptosporidium parvum are intracellular protozoan parasites that establish infection through the small intestinal bowel after the ingestion of contaminated food products. These Apicomplexan parasites have emerged as an important cause of chronic and fatal disease in immunodeficient individuals, in addition to being investigated as possible triggers of inflammatory bowel disease. T. gondii disseminates to the brain and other tissues after infection, whereas C. parvum remains localized to the intestine. In the following review, we will discuss the pathogenesis of these parasitic diseases in the small intestine, the site of initial invasion. Themes include the sequence of invasion, the structure of Th1 immunity provoked by these parasites and the contribution of intestinal microbiota to the development of the mucosal immune response.
Keywords: Cryptosporidium parvum; IFNg; Th1; Toxoplasma gondii; microbiota; parasite.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Cryptosporidium and host resistance: historical perspective and some novel approaches.Anim Health Res Rev. 2003 Jun;4(1):53-62. doi: 10.1079/ahrr200352. Anim Health Res Rev. 2003. PMID: 12885209 Review.
-
Mucosal immunity in Toxoplasma gondii infection.Parasite. 2008 Sep;15(3):389-95. doi: 10.1051/parasite/2008153389. Parasite. 2008. PMID: 18814712 Review.
-
Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum.Int J Parasitol Drugs Drug Resist. 2022 Aug;19:6-20. doi: 10.1016/j.ijpddr.2022.04.001. Epub 2022 Apr 16. Int J Parasitol Drugs Drug Resist. 2022. PMID: 35462232 Free PMC article.
-
Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.Immunobiology. 2009;214(6):454-66. doi: 10.1016/j.imbio.2008.11.015. Epub 2009 Jan 19. Immunobiology. 2009. PMID: 19155092
-
Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.Mucosal Immunol. 2014 Jul;7(4):744-52. doi: 10.1038/mi.2014.25. Epub 2014 Apr 9. Mucosal Immunol. 2014. PMID: 24717355 Review.
Cited by
-
Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion.Sci Rep. 2015 Jul 1;5:11599. doi: 10.1038/srep11599. Sci Rep. 2015. PMID: 26129968 Free PMC article.
-
SHP-2 Mediates Cryptosporidium parvum Infectivity in Human Intestinal Epithelial Cells.PLoS One. 2015 Nov 10;10(11):e0142219. doi: 10.1371/journal.pone.0142219. eCollection 2015. PLoS One. 2015. PMID: 26556238 Free PMC article.
-
Parasites and Microbiota: Dual Interactions and Therapeutic Perspectives.Microorganisms. 2024 Oct 16;12(10):2076. doi: 10.3390/microorganisms12102076. Microorganisms. 2024. PMID: 39458384 Free PMC article. Review.
-
Interferon-Inducible E3 Ligase RNF213 Facilitates Host-Protective Linear and K63-Linked Ubiquitylation of Toxoplasma gondii Parasitophorous Vacuoles.mBio. 2022 Oct 26;13(5):e0188822. doi: 10.1128/mbio.01888-22. Epub 2022 Sep 26. mBio. 2022. PMID: 36154443 Free PMC article.
-
Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.Curr Trop Med Rep. 2015 Sep 1;2(3):171-180. doi: 10.1007/s40475-015-0054-y. Curr Trop Med Rep. 2015. PMID: 26279971 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical